BioAtla

BioAtla heads for Nasdaq on Wednesday following $189M IPO, going public with its pH-detecting cancer treatments
Endpoints
Wed, 12/16/20 - 11:32 am
BioAtla
IPOs
NASDAQ
4 Companies Pfizer Just Increased Its Stake In
Yahoo/Benzinga
Mon, 01/11/16 - 11:59 am
Pfizer
BioAtla
NextCure
Cortexyme
4D Molecular Therapeutics
Pfizer bets up to $1B on BioAtla's approach to immuno-oncology
Fierce Biotech
Wed, 12/9/15 - 09:39 am
Pfizer
BioAtla
immuno-oncology